Citadel Advisors’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Buy |
|
|||||
|
2025
Q1 | $9.4M | Sell |
|
|||||
|
2024
Q4 | $10.1M | Sell |
|
|||||
|
2024
Q3 | $10.8M | Buy |
|
|||||
|
2024
Q2 | $5.26M | Buy |
|
|||||
|
2024
Q1 | $1.19M | Sell |
|
|||||
|
2023
Q4 | $2.15M | Sell |
|
|||||
|
2023
Q3 | $4.85M | Buy |
|
|||||
|
2023
Q2 | $515K | Sell |
|
|||||
|
2023
Q1 | $20.5M | Sell |
|
|||||
|
2022
Q4 | $20.1M | Sell |
|
|||||
|
2022
Q3 | $27.1M | Sell |
|
|||||
|
2022
Q2 | $31.6M | Sell |
|
|||||
|
2022
Q1 | $37.1M | Buy |
|
|||||
|
2021
Q4 | $25.7M | Buy |
|
|||||
|
2021
Q3 | $19.5M | Buy |
|
|||||
|
2021
Q2 | $356K | Buy |
|
|||||
|
2021
Q1 | $480K | Sell |
|
|||||
|
2020
Q4 | $26.3M | Buy |
|
|||||
|
2020
Q3 | $11.6M | Buy |
|
|||||
|
2020
Q2 | $7.2M | Buy |
|
|||||
|
2020
Q1 | $1.67M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1.68M | Sell |
|
|||||
|
2019
Q2 | $7.01M | Buy |
|
|||||
|
2019
Q1 | $2.23M | Buy |
|
|||||
|
2018
Q4 | $1.65M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.39M | Sell |
|
|||||
|
2018
Q1 | $1.64M | Sell |
|
|||||
|
2017
Q4 | $7.55M | Sell |
|
|||||
|
2017
Q3 | $10.2M | Sell |
|
|||||
|
2017
Q2 | $11.8M | Sell |
|
|||||
|
2017
Q1 | $14.9M | Buy |
|
|||||
|
2016
Q4 | $5.17M | Buy |
|
|||||
|
2016
Q3 | $1.54M | Sell |
|
|||||
|
2016
Q2 | $10.4M | Buy |
|
|||||
|
2016
Q1 | $2.22M | Buy |
|
|||||
|
2015
Q4 | $2.89M | Buy |
|
|||||
|
2015
Q3 | $2.66M | Buy |
|
|||||
|
2015
Q2 | $3.77M | Buy |
|
|||||
|
2015
Q1 | $1.04M | Buy |
|
|||||
|
2014
Q4 | $274K | Buy |
|
|||||
|
2014
Q3 | $19K | Sell |
|
|||||
|
2014
Q2 | $190K | Sell |
|
|||||
|
2014
Q1 | $568K | Buy |
|